In an effort to identify novel binding sites for cocaine and its analo
gs, we carried out binding studies with the high-affinity and selectiv
e ligand [I-125]RTI-121 in rat frontal cortical tissue. Very low densi
ties of binding sites were found. Saturation analysis revealed that th
e binding was to both high- and low-affinity sites. Pharmacological co
mpetition studies were carried out with inhibitors of the dopamine, no
repinephrine, and serotonin transporters. The various transporter inhi
bitors inhibited the binding of 15 pM [I-125]RTI-121 in a biphasic fas
hion following a two-site binding model. The resultant data were compl
ex and did not suggest a simple association with any single transporte
r. Correlational analysis supported the following hypothesis: [I-125]
RTI-121 binds to known transporters and not to novel sites; these incl
ude dopamine, norepinephrine, and serotonin transporters. Immunoprecip
itation of transporters photoaffinity labeled with [(125)] RTI-82 and
subsequent analysis of SDS-page gels revealed the presence of authenti
c dopamine transporters in these samples; displacement of the photoaff
inity label occurred with a typical dopamine transporter pharmacology.
These data are compatible with the binding properties of RTI-181 and
the presence of several known transporters in the tissue studied. Syna
pse 30:9-17, 1998. (C) 1998 Wiley-Liss, Inc.dagger